At Innova Medical Group, we believe better healthcare outcomes around the globe are within reach – and it starts with scalable and cost-effective screening and diagnostic options. The company was founded at the beginning of 2020 with a mission to help tackle some of the world’s most challenging healthcare problems. Little did we know that by April 2020, COVID-19 would become a global pandemic that cost millions of lives and shut down many economies. We looked for ways to support our customers and help them manage COVID and by October 2020, we were producing tens of millions of test kits per day and delivering them across the world.
The global pandemic has ushered in a new era of virtual care and illustrated the need for better testing solutions beyond COVID-19. To help meet these needs, Innova is determined to execute the model we pioneered with COVID-19 across other infectious diseases, chronic conditions and wellness, thereby empowering the global population to take control of their own care procurement and health decisions. Our goal is to play an integral role in care pathways by vitally contributing to improving patient outcomes and ultimately cutting overall treatment costs while bettering lives.
